# ViroForge Mock Virome Creation Workflow

**Purpose**: This document describes the complete workflow for creating mock virome datasets, including when and how different components are added, modified, and processed.

**Last Updated**: 2025-01-31
**Status**: Phase 1 Complete, Phase 2 in Development

---

## Table of Contents

1. [Overview](#overview)
2. [Phase 1 Workflow (Current)](#phase-1-workflow-current)
3. [Phase 2 Workflow (In Development)](#phase-2-workflow-in-development)
4. [Component Details](#component-details)
5. [Order of Operations](#order-of-operations)
6. [Examples](#examples)

---

## Overview

ViroForge creates realistic mock virome datasets through a multi-stage pipeline that mimics the biological and technical processes of real virome sequencing. Understanding the order of operations is critical because **each stage modifies either genome abundances or read sequences**.

### Key Principle: Two Types of Modifications

| Modification Type | What Changes | When Applied | Examples |
|-------------------|--------------|--------------|----------|
| **Abundance-Modifying** | Relative abundance of genomes | BEFORE read generation | VLP enrichment, amplification bias, library prep bias |
| **Read-Modifying** | The reads themselves | AFTER read generation | PolyG tails, optical duplicates, quality scores |

---

## Phase 1 Workflow (Current)

**Status**: âœ… Fully Implemented and Tested

### Pipeline Stages

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 1: VIRAL COMMUNITY CREATION                           â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Sample or create viral genomes                            â”‚
â”‚ â€¢ Assign taxonomic information                              â”‚
â”‚ â€¢ Apply abundance distribution (lognormal, powerlaw, even)  â”‚
â”‚                                                              â”‚
â”‚ Output: ViralCommunity object                               â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 2: CONTAMINATION PROFILE CREATION                     â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Add host DNA (human, mouse, etc.)                         â”‚
â”‚ â€¢ Add rRNA contamination (bacterial, archaeal, eukaryotic)  â”‚
â”‚ â€¢ Add reagent bacteria (kit contamination)                  â”‚
â”‚ â€¢ Add PhiX174 control spike-in                              â”‚
â”‚                                                              â”‚
â”‚ Output: ContaminationProfile object                         â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 3: COMPOSITION ASSEMBLY                               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Combine viral community + contamination profile           â”‚
â”‚ â€¢ Normalize abundances to target viral_fraction             â”‚
â”‚ â€¢ Example: 85% viral, 15% contamination                     â”‚
â”‚                                                              â”‚
â”‚ Output: MockViromeComposition object                        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 4: READ GENERATION (InSilicoSeq)                      â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Write genomes + abundances to temp files                  â”‚
â”‚ â€¢ Call InSilicoSeq with platform error model                â”‚
â”‚ â€¢ Generate paired-end FASTQ reads                           â”‚
â”‚ â€¢ Validate every FASTQ record (seq/qual length match)       â”‚
â”‚                                                              â”‚
â”‚ Output: R1/R2 FASTQ files + ground truth metadata           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
```

### Code Example (Phase 1)

```python
from viroforge.core import create_body_site_profile, create_contamination_profile
from viroforge.utils import MockViromeComposition
from viroforge.simulators import generate_reads

# Stage 1: Create viral community
viral_community = create_body_site_profile(
    body_site='gut',
    n_genomes=50,
    random_seed=42
)

# Stage 2: Create contamination profile
contamination = create_contamination_profile(
    profile='realistic',  # 2% host, 5% rRNA, 0.5% bacteria, 0.1% PhiX
    host_organism='human',
    random_seed=42
)

# Stage 3: Combine into composition
composition = MockViromeComposition(
    name='gut_virome_realistic',
    viral_community=viral_community,
    contamination_profile=contamination,
    viral_fraction=0.85  # 85% viral, 15% contamination
)

# Stage 4: Generate reads
output = generate_reads(
    composition=composition,
    output_prefix='my_dataset',
    n_reads=1_000_000,
    model='NovaSeq',
    random_seed=42
)

# Output: my_dataset_R1.fastq.gz, my_dataset_R2.fastq.gz, ground_truth.tsv
```

---

## Phase 2 Workflow (In Development)

**Status**: ğŸš§ Planned for Implementation (Weeks 1-12)

### Extended Pipeline with Virome-Specific Features

```
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 1: VIRAL COMMUNITY CREATION                           â”‚
â”‚ (Same as Phase 1)                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 2: CONTAMINATION PROFILE CREATION                     â”‚
â”‚ (Same as Phase 1)                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 3: INITIAL COMPOSITION (Pre-Enrichment)               â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Combine viral + contamination (BULK METAGENOME state)     â”‚
â”‚ â€¢ Represents sample BEFORE any lab processing               â”‚
â”‚ â€¢ Example: 50% viral, 30% host, 15% rRNA, 5% bacteria       â”‚
â”‚                                                              â”‚
â”‚ Output: MockViromeComposition (pre-enrichment)              â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 4: VLP ENRICHMENT (ABUNDANCE-MODIFYING) ğŸ†•             â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Apply size-based filtration (0.2-0.45 Î¼m)                 â”‚
â”‚ â€¢ Apply nuclease treatment (removes free DNA)               â”‚
â”‚ â€¢ Apply family-specific enrichment factors                  â”‚
â”‚ â€¢ Dramatically increases viral fraction                     â”‚
â”‚                                                              â”‚
â”‚ MODIFIES: Genome abundances                                 â”‚
â”‚ Example: 50% viral â†’ 95% viral, host 30% â†’ 0.5%            â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 5: AMPLIFICATION BIAS (ABUNDANCE-MODIFYING) ğŸ†•         â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Apply method-specific bias (RdAB, MDA, Linker, or none)  â”‚
â”‚ â€¢ Length-dependent amplification (short favored)            â”‚
â”‚ â€¢ GC-dependent amplification                                â”‚
â”‚ â€¢ Cycle-dependent scaling                                   â”‚
â”‚                                                              â”‚
â”‚ MODIFIES: Genome abundances                                 â”‚
â”‚ Example: Short genomes 10x enriched after 40 PCR cycles    â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 6: LIBRARY PREP BIAS (ABUNDANCE-MODIFYING) ğŸ†•          â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Apply fragmentation method bias                           â”‚
â”‚   - Mechanical shearing: minimal bias                       â”‚
â”‚   - Tagmentation (Nextera): GC-dependent bias               â”‚
â”‚   - Enzymatic: moderate bias                                â”‚
â”‚                                                              â”‚
â”‚ MODIFIES: Genome abundances (within-genome coverage)        â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 7: READ GENERATION (InSilicoSeq)                      â”‚
â”‚ (Same as Phase 1)                                           â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
â”Œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”
â”‚ Stage 8: PLATFORM ARTIFACTS (READ-MODIFYING) ğŸ†•              â”‚
â”œâ”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”¤
â”‚ â€¢ Add polyG tails (NovaSeq 2-channel chemistry)             â”‚
â”‚ â€¢ Add optical duplicates (patterned flow cells)             â”‚
â”‚ â€¢ Add index hopping (multiplexed samples)                   â”‚
â”‚                                                              â”‚
â”‚ MODIFIES: Read sequences themselves                         â”‚
â”‚ Example: 20% of reads get polyG tails added                 â”‚
â””â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”€â”˜
                            â†“
                   FINAL FASTQ OUTPUT
```

### Code Example (Phase 2)

```python
from viroforge.core import create_body_site_profile, create_contamination_profile
from viroforge.utils import MockViromeComposition
from viroforge.enrichment import VLPEnrichment  # ğŸ†• Phase 2
from viroforge.amplification import RdABAmplification  # ğŸ†• Phase 2
from viroforge.library_prep import MechanicalShearing  # ğŸ†• Phase 2
from viroforge.simulators import generate_reads

# Stages 1-2: Create base components (same as Phase 1)
viral_community = create_body_site_profile('gut', n_genomes=50, random_seed=42)
contamination = create_contamination_profile('realistic', random_seed=42)

# Stage 3: Create BULK METAGENOME composition (pre-enrichment)
composition = MockViromeComposition(
    name='gut_virome',
    viral_community=viral_community,
    contamination_profile=contamination,
    viral_fraction=0.50  # 50% viral BEFORE enrichment (bulk state)
)

# Stage 4: Apply VLP enrichment ğŸ†•
vlp = VLPEnrichment(
    filtration_cutoff_um=0.2,
    nuclease_efficiency=0.95
)
vlp.apply(composition)  # Now ~95% viral after enrichment!

# Stage 5: Apply amplification bias ğŸ†•
rdab = RdABAmplification(cycles=40)
rdab.apply(composition)  # Short genomes now over-represented

# Stage 6: Apply library prep bias ğŸ†•
shearing = MechanicalShearing()
shearing.apply(composition)  # Minimal bias for mechanical shearing

# Stage 7: Generate reads
output = generate_reads(
    composition=composition,
    output_prefix='my_vlp_dataset',
    n_reads=1_000_000,
    model='NovaSeq',
    random_seed=42
)

# Stage 8: Platform artifacts ğŸ†•
# (This happens automatically inside generate_reads or as post-processing)
# - PolyG tails added to 20% of reads
# - Optical duplicates created at 5% rate
```

---

## Component Details

### 1. Viral Community

**What it contains:**
- Collection of viral genomes (synthetic or real)
- Taxonomic assignments (family, genus, species)
- Relative abundances following specified distribution
- Genome sequences (or placeholders)

**Sources:**
- Synthetic genomes (current default): Random sequences of realistic lengths
- Real genomes (optional): Sampled from FASTA databases (RefSeq, IMG/VR, custom)

**Abundance distributions:**
- **Log-normal** (realistic): Most viromes, some dominant species, long tail
- **Power-law** (highly uneven): Few hyper-dominant species, steep decline
- **Even** (synthetic control): All species equal abundance

### 2. Contamination Profile

**What it contains:**
- Host DNA fragments (human, mouse, or custom organism)
- rRNA sequences (bacterial 16S/23S, archaeal, eukaryotic 18S/28S)
- Reagent bacteria genomes (kit contamination: *Delftia*, *Ralstonia*, etc.)
- PhiX174 spike-in control

**Contamination levels:**

| Level | Host DNA | rRNA | Reagent Bacteria | PhiX | Total Contam | Use Case |
|-------|----------|------|------------------|------|--------------|----------|
| **clean** | 0.1% | 0.5% | 0.1% | 0.1% | 0.8% | Excellent VLP enrichment |
| **realistic** | 2.0% | 5.0% | 0.5% | 0.1% | 7.6% | Typical VLP-enriched virome |
| **heavy** | 10.0% | 15.0% | 2.0% | 0.1% | 27.1% | Poor VLP enrichment |
| **failed** | 15.0% | 20.0% | 4.0% | 0.1% | 39.1% | Complete VLP failure |

### 3. VLP Enrichment (Phase 2)

**What it does:**
- Models physical separation of virus-like particles from cells/debris
- Applies size-based retention (0.2-0.45 Î¼m filtration)
- Applies nuclease treatment efficiency (removes free DNA)
- Applies family-specific enrichment factors (from ViromeQC literature)

**Effect on composition:**
- Viral fraction increases dramatically (50% â†’ 95%)
- Host DNA decreases 10-100x (30% â†’ 0.3-3%)
- rRNA decreases 5-20x (15% â†’ 0.75-3%)
- Reagent bacteria partially removed
- Small viruses slightly enriched, large viruses slightly depleted

**See**: [VLP_ENRICHMENT_BIOLOGY.md](VLP_ENRICHMENT_BIOLOGY.md) for detailed explanation

### 4. Amplification Bias (Phase 2)

**What it does:**
- Models PCR or isothermal amplification effects on abundances
- Length-dependent bias (short genomes amplify better)
- GC-dependent bias (moderate GC optimal)
- Method-specific characteristics (RdAB, MDA, Linker, None)

**Methods:**

| Method | Length Bias | GC Bias | Stochasticity | Use Case |
|--------|-------------|---------|---------------|----------|
| **RdAB** | Strong | Moderate | Low | Standard virome protocol (40 cycles) |
| **MDA** | Minimal | Extreme | High | Low-biomass samples, marine viromes |
| **Linker** | Minimal | Weak | Low | Alternative amplification method |
| **None** | None | None | None | High-biomass samples, no amplification |

### 5. Library Prep Bias (Phase 2)

**What it does:**
- Models fragmentation method effects on sequence representation
- GC-dependent coverage for tagmentation
- Uniform coverage for mechanical shearing

**Methods:**
- **Mechanical shearing** (Covaris, sonication): Minimal bias, uniform coverage
- **Tagmentation** (Nextera, Tn5): GC bias, AT-rich underrepresented
- **Enzymatic** (NEBNext, KAPA): Intermediate bias

### 6. Platform Artifacts (Phase 2)

**What it does:**
- Adds platform-specific sequencing artifacts to reads
- Does NOT change genome abundances, modifies read sequences

**Artifacts:**

| Platform | PolyG Tails | Optical Duplicates | Index Hopping |
|----------|-------------|-------------------|---------------|
| **NovaSeq** | Yes (20%) | Yes (5%) | Yes (0.5%) |
| **MiSeq** | No | Low (1%) | Minimal |
| **HiSeq** | No | Low (1%) | Minimal |

---

## Order of Operations

### Critical Sequence Understanding

The order matters because **earlier stages affect what later stages act upon**:

```
BIOLOGICAL SAMPLE
        â†“
[Contamination is PRESENT]
        â†“
VLP ENRICHMENT â† Reduces contamination, enriches viruses
        â†“
ENRICHED SAMPLE (mostly viral)
        â†“
AMPLIFICATION â† Biases viral abundances
        â†“
AMPLIFIED DNA (biased abundances)
        â†“
LIBRARY PREP â† Fragments DNA, may introduce bias
        â†“
LIBRARY (ready for sequencing)
        â†“
SEQUENCING â† Adds platform artifacts
        â†“
RAW FASTQ READS
```

### Example: Following Host DNA Through Pipeline

```
Initial Sample (bulk metagenome):
â”œâ”€â”€ Host DNA: 30% of total DNA

After VLP Enrichment (0.2 Î¼m filtration + 95% nuclease):
â”œâ”€â”€ Most host cells removed (too large)
â”œâ”€â”€ Free host DNA degraded (95% efficiency)
â”œâ”€â”€ Small host DNA fragments remain
â””â”€â”€ Host DNA: 0.5% of total DNA (60x reduction)

After Amplification (RdAB 40 cycles):
â”œâ”€â”€ Host DNA fragments amplify
â”œâ”€â”€ But viral genomes may amplify better (shorter on average)
â””â”€â”€ Host DNA: 0.3% of total DNA (viral preferentially amplified)

After Library Prep (mechanical shearing):
â”œâ”€â”€ Host DNA fragmented uniformly
â””â”€â”€ Host DNA: 0.3% of total DNA (no change)

After Sequencing (NovaSeq):
â”œâ”€â”€ Some host DNA reads get polyG tails (20% of all reads)
â””â”€â”€ Host DNA: 0.3% of reads in FASTQ
```

### Example: Comparing VLP vs Bulk from Same Starting Community

```python
# Create one starting community
base_viral_community = create_body_site_profile('gut', n_genomes=50, random_seed=42)
base_contamination = create_contamination_profile('realistic', random_seed=42)

# VLP-ENRICHED WORKFLOW
vlp_composition = MockViromeComposition(
    name='vlp_enriched',
    viral_community=base_viral_community.copy(),  # Same community
    contamination_profile=base_contamination.copy(),  # Same contamination
    viral_fraction=0.50  # Start as bulk (50% viral)
)

vlp_enrichment = VLPEnrichment(filtration_cutoff_um=0.2, nuclease_efficiency=0.95)
vlp_enrichment.apply(vlp_composition)  # Now ~95% viral

vlp_output = generate_reads(vlp_composition, 'vlp_dataset', n_reads=1_000_000)

# BULK METAGENOME WORKFLOW (NO ENRICHMENT)
bulk_composition = MockViromeComposition(
    name='bulk_metagenome',
    viral_community=base_viral_community.copy(),  # Same community
    contamination_profile=base_contamination.copy(),  # Same contamination
    viral_fraction=0.50  # Stays as bulk (50% viral)
)

# NO VLP enrichment applied!
bulk_output = generate_reads(bulk_composition, 'bulk_dataset', n_reads=1_000_000)

# RESULT:
# - Both datasets have SAME viral species
# - But VERY DIFFERENT abundances
# - VLP: 95% viral reads, Bulk: 50% viral reads
# - VLP: 0.5% host DNA, Bulk: 30% host DNA
```

---

## Examples

### Example 1: Phase 1 Simple Dataset

```python
from viroforge.simulators import quick_generate

# One-liner - creates gut virome with realistic contamination
output = quick_generate(
    body_site='gut',
    contamination_level='realistic',
    n_reads=1_000_000,
    random_seed=42
)

# Output:
# - reads_R1.fastq.gz: Forward reads
# - reads_R2.fastq.gz: Reverse reads
# - ground_truth_abundance.tsv: True abundances
# - ground_truth_taxonomy.tsv: Taxonomic assignments
```

### Example 2: Phase 1 Custom Contamination

```python
from viroforge.core import create_body_site_profile, create_contamination_profile
from viroforge.utils import MockViromeComposition
from viroforge.simulators import generate_reads

# Create custom contamination
contamination = create_contamination_profile(
    profile='realistic',
    host_dna_pct=5.0,      # Override: 5% instead of 2%
    rrna_pct=10.0,         # Override: 10% instead of 5%
    phix_pct=0.5           # Override: 0.5% instead of 0.1%
)

# Create composition
composition = MockViromeComposition(
    name='custom_contamination',
    viral_community=create_body_site_profile('gut', n_genomes=50),
    contamination_profile=contamination,
    viral_fraction=0.85
)

# Generate reads
output = generate_reads(composition, 'custom_dataset', n_reads=1_000_000)
```

### Example 3: Phase 2 VLP vs Bulk Comparison (Planned)

```python
from viroforge.enrichment import VLPEnrichment, no_enrichment

# Create base composition (same for both)
base_community = create_body_site_profile('gut', n_genomes=50, random_seed=42)
base_contamination = create_contamination_profile('realistic', random_seed=42)

# VLP-ENRICHED
vlp_comp = MockViromeComposition(
    'vlp', base_community.copy(), base_contamination.copy(), viral_fraction=0.50
)
VLPEnrichment(filtration_cutoff_um=0.2).apply(vlp_comp)
vlp_output = generate_reads(vlp_comp, 'vlp_dataset', n_reads=1_000_000)

# BULK METAGENOME
bulk_comp = MockViromeComposition(
    'bulk', base_community.copy(), base_contamination.copy(), viral_fraction=0.50
)
# No enrichment applied
bulk_output = generate_reads(bulk_comp, 'bulk_dataset', n_reads=1_000_000)

# Compare results to test if your pipeline handles them differently
```

### Example 4: Phase 2 Complete Workflow (Planned)

```python
from viroforge.enrichment import VLPEnrichment
from viroforge.amplification import RdABAmplification
from viroforge.library_prep import MechanicalShearing
from viroforge.platform import NovaSeqPlatform

# Create base composition
composition = MockViromeComposition(
    name='complete_workflow',
    viral_community=create_body_site_profile('gut', 50),
    contamination_profile=create_contamination_profile('realistic'),
    viral_fraction=0.50  # Bulk starting state
)

# Apply full processing pipeline
VLPEnrichment(filtration_cutoff_um=0.2, nuclease_efficiency=0.95).apply(composition)
RdABAmplification(cycles=40).apply(composition)
MechanicalShearing().apply(composition)

# Generate reads with platform artifacts
output = generate_reads(
    composition,
    'complete_dataset',
    n_reads=1_000_000,
    model='NovaSeq',
    add_artifacts=True  # PolyG tails, optical duplicates
)
```

---

## Summary

### Key Takeaways

1. **Order matters**: Contamination â†’ Enrichment â†’ Amplification â†’ Library Prep â†’ Sequencing â†’ Artifacts

2. **Two types of modifications**:
   - Abundance-modifying (changes genome ratios)
   - Read-modifying (changes read sequences)

3. **Phase 1 is complete and working**: Viral community + contamination + read generation

4. **Phase 2 adds virome-specific features**: VLP enrichment, amplification bias, platform artifacts

5. **VLP enrichment is the key differentiator**: Transforms bulk metagenome into virome

6. **Flexibility at every stage**: Users can customize all parameters or use pre-defined templates

---

## See Also

- [VLP_ENRICHMENT_BIOLOGY.md](VLP_ENRICHMENT_BIOLOGY.md) - Detailed explanation of VLP enrichment biology
- [IMPLEMENTATION_PLAN.md](IMPLEMENTATION_PLAN.md) - Phase 2 implementation timeline
- [DESIGN_RATIONALE.md](DESIGN_RATIONALE.md) - Original design document
- [examples/](../examples/) - Code examples for all use cases

---

**Questions or feedback?** Open an issue at https://github.com/shandley/viroforge/issues
